CoChat

Sarcopenia Exacerbates Obesity-Associated Insulin Resistance and Dysglycemia: Findings from the National Health and Nutrition Examination Survey III

Open access

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Sarcopenia often co-exists with obesity, and may have additive effects on insulin resistance. Sarcopenic obese individuals could be at increased risk for type 2 diabetes. We performed a study to determine whether sarcopenia is associated with impairment in insulin sensitivity and glucose homeostasis in obese and non-obese individuals. METHODOLOGY: We performed a cross-sectional analysis of National Health and Nutrition Examination Survey III data utilizing subjects of 20 years or older, non-pregnant (N = 14,528). Sarcopenia was identified from bioelectrical impedance measurement of muscle mass. Obesity was identified from body mass index. Outcomes were homeostasis model assessment of insulin resistance (HOMA IR), glycosylated hemoglobin level (HbA1C), and prevalence of pre-diabetes (6.0≤ HbA1C<6.5 and not on medication) and type 2 diabetes. Covariates in multiple regression were age, educational level, ethnicity and sex. PRINCIPAL FINDINGS: Sarcopenia was associated with insulin resistance in non-obese (HOMA IR ratio 1.39, 95% confidence interval (CI) 1.26 to 1.52) and obese individuals (HOMA-IR ratio 1.16, 95% CI 1.12 to 1.18). Sarcopenia was associated with dysglycemia in obese individuals (HbA1C ratio 1.021, 95% CI 1.011 to 1.043) but not in non-obese individuals. Associations were stronger in those under 60 years of age. We acknowledge that the cross-sectional study design limits our ability to draw causal inferences. CONCLUSIONS: Sarcopenia, independent of obesity, is associated with adverse glucose metabolism, and the association is strongest in individuals under 60 years of age, which suggests that low muscle mass may be an early predictor of diabetes susceptibility. Given the increasing prevalence of obesity, further research is urgently needed to develop interventions to prevent sarcopenic obesity and its metabolic consequences.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0010805

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 600

Metadata

Authors
Srikanthan, P., Hevener, A. L., & Karlamangla, A. S.
Affiliations
University of California, Los Angeles (US)
Corresponding author
Srikanthan, Preethi
Venue
PLoS ONE
Published
2010-05-26
Volume
5
Issue
5
Pages
e10805
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1977023983
Cited by
600
References
24
Citations by year
2026: 14 · 2025: 42 · 2024: 37 · 2023: 66 · 2022: 51 · 2021: 45 · 2020: 62 · 2019: 46 · 2018: 34 · 2017: 41 · 2016: 35 · 2015: 45 · 2014: 30 · 2013: 32 · 2012: 12
FWCI
11.26
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health (n01hc95165-34-0-1, n01hc095169-003, N01-HC- 95159, n01hc95159-40-0-1, N01- HC-95165, N01‐HC‐95169, AG028748, and N01-HC-95169)
  • National Institute on Aging (N01-HC-95169, 5R01AG26105-3, N01‐HC‐95159, N01-HC-95165, R01AG026105, P30AG028748)
  • National Heart, Lung, and Blood Institute (N01 HC-95159, N01-HC095169, N01-HC-095165, N01 HC95165, N01-HC-095159, N01-HC, HC95159, N01 HC95169)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK060484, K01DK060484, R21DK073227, DK-073227)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords
sarcopenia, obesity, insulin resistance, dysglycemia, type 2 diabetes, prediabetes, glucose homeostasis, muscle mass, HOMA-IR, HbA1c, sarcopenic obesity, diabetes risk prediction
MeSH terms
Adult, Age Factors, Aged, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Educational Status, Female, Humans, Insulin Resistance, Male, Middle Aged, Nutrition Surveys, Obesity, Prediabetic State, Sex Factors, United States, Comorbidity, Prevalence, Multivariate Analysis, Linear Models, Glucose Intolerance, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sarcopenia Exacerbates Obesity-Associated Insulin Resistance and Dysglycemia: Findings from the National Health and Nutrition Examination Survey III. https://app.cochat.ai/papers/10.1371/journal.pone.0010805
The paper
Srikanthan, P., Hevener, A. L., & Karlamangla, A. S. (2010). Sarcopenia Exacerbates Obesity-Associated Insulin Resistance and Dysglycemia: Findings from the National Health and Nutrition Examination Survey III. PLoS ONE. https://doi.org/10.1371/journal.pone.0010805

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.